iCarbonX

iCarbonX is a healthcare company in Beijing, China, founded in 2015. It has raised $45.0M across 1 round, most recently a $45.0M Series A in July 2016.

Building a Digital Life Ecosystem

Headquarters
Beijing
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$45.0M
Last Round
$45.0M Series AJul 2016
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

iCarbonX is a Chinese precision medicine and digital life company founded in October 2015 by Jun Wang, former CEO of the Beijing Genomics Institute, along with co-founders Hao Li and Yingrui Li. The company combines genomics with other multi-omics data including proteomics, metabolomics, microbiome analysis, and behavioral data to build comprehensive digital models of individual human health. Its AI platform analyzes billions of biological and lifestyle data points to generate personalized health insights, disease risk predictions, and wellness optimization recommendations. In 2017, iCarbonX launched the Digital Health Alliance with $400 million in venture capital backing to drive wellness research and advance healthcare beyond genetics toward holistic wellness predictions.

Summary

It lists 51–200 employees. It has raised $45.0M in total across 1 round, most recently a $45.0M Series A round in Jul 2016. Investors include Quan Capital and Ronglian Group.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJul 2016
$45.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

iCarbonX on Indexed.vc
<a href="https://indexed.vc/companies/icarbonx"><img src="https://indexed.vc/api/badge/company/icarbonx" alt="iCarbonX on Indexed.vc" width="260" height="76" /></a>